MTHFR gene polymorphisms in bladder cancer in the Turkish population

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Bladder cancer is a significant global health concern, ranking as the 9th most common malignancy.
• Folate metabolism and associated enzyme polymorphisms are implicated in various cancer risks.
• The methylene tetrahydrofolate reductase (MTHFR) enzyme plays a crucial role in folate pathways.

Purpose of the Study:

• To investigate the prevalence of MTHFR gene polymorphisms (C677T and A1298C) in relation to bladder cancer in the Turkish population.
• To assess the association between specific MTHFR gene variants and bladder cancer risk.
• To determine if MTHFR gene polymorphisms contribute to bladder cancer susceptibility in Turkey.

Main Methods:

• Case-control study design involving bladder cancer patients and healthy controls from Turkey.
• Utilized Polymerase Chain Reaction (PCR) and Restriction Fragment Length Polymorphism (RFLP) techniques.
• Genotyping of MTHFR gene C677T and A1298C polymorphisms.

Main Results:

• The MTHFR gene C677T polymorphism showed a statistically significant association with an increased risk of bladder cancer (p=0.036).
• The MTHFR gene A1298C polymorphism did not show a significant association with bladder cancer risk (p=0.278).
• The C677T variant of the MTHFR gene appears to augment bladder cancer risk in the studied Turkish population.

Conclusions:

• The MTHFR gene C677T polymorphism is a contributing factor to bladder cancer risk in Turkey.
• Further research may explore the functional implications of the MTHFR C677T variant in bladder carcinogenesis.
• Understanding genetic predispositions like MTHFR polymorphisms can aid in personalized risk assessment for bladder cancer.